Format

Send to:

Choose Destination
See comment in PubMed Commons below
Expert Rev Med Devices. 2009 Jul;6(4):401-10. doi: 10.1586/erd.09.23.

Artificial pancreas: an emerging approach to treat Type 1 diabetes.

Author information

  • 1Institute of Metabolic Science, University of Cambridge, Metabolic Research Laboratories, Box 289, Level 4, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK. kk426@medschl.cam.ac.uk

Abstract

Intensive insulin therapy aimed at achieving normal glucose levels significantly reduces the complications that are associated with diabetes but is also associated with an increased risk of low glucose levels (hypoglycemia). The growing use of continuous glucose monitors has stimulated the development of the artificial pancreas, a closed-loop insulin-delivery system aimed at restoring near-normal glucose levels while reducing the risk of hypoglycemia. The artificial pancreas comprises three components: a continuous glucose monitor, an insulin infusion pump and a control algorithm delivering insulin according to real-time glucose readings. In this article, we review closed-loop glucose control, including its components, development, testing and clinical application.

PMID:
19572795
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Write to the Help Desk